Erste Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Erste Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.95M	Hold	27,000	–	–	0.02%	341
2026 Q1	$2.15M	Hold	27,000	–	–	0.02%	357
2025 Q4	$2.17M	Hold	27,000	–	–	0.02%	344
2025 Q3	$1.58M	Hold	27,000	–	–	0.02%	369
2025 Q2	$1.19M	Hold	27,000	–	–	0.01%	475
2025 Q1	$800K	Hold	27,000	–	–	0.01%	396
2024 Q4	$1.08M	Hold	27,000	–	–	0.01%	376
2024 Q3	$1.31M	Hold	27,000	–	–	0.02%	362
2024 Q2	$816K	Hold	27,000	–	–	0.01%	390
2024 Q1	$1.08M	Hold	27,000	–	–	0.01%	362
2023 Q4	$724K	Hold	27,000	–	–	0.01%	399
2023 Q3	$386K	Hold	27,000	–	–	0.01%	431
2023 Q2	$605K	Hold	27,000	–	–	0.01%	400
2023 Q1	$763K	Hold	27,000	–	–	0.01%	394
2022 Q4	$692K	Buy	27,000 +16,000	+145%	+$427K	0.01%	398
2022 Q3	$243K	Hold	11,000	–	–	0.01%	484
2022 Q2	$223K	Hold	11,000	–	–	0.01%	506
2022 Q1	$457K	Buy	+11,000	New	+$465K	0.01%	444

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Erste Asset Management's KYMR Position: Q2 2026 in Review

Erste Asset Management held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 27,000 shares worth $2.95M. The position accounts for 0.02% of the portfolio, ranked #341.

Erste Asset Management first reported a position in KYMR in Q1 2022 and has held it in 18 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Erste Asset Management held 27,000 shares of Kymera Therapeutics worth $2.95M as of Q2 2026.
Erste Asset Management left its Kymera Therapeutics share count unchanged in Q2 2026.
Kymera Therapeutics made up 0.02% of Erste Asset Management's portfolio in Q2 2026, its #341 holding.
Erste Asset Management first reported a position in Kymera Therapeutics in Q1 2022 and has held it in 18 quarters since.
275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.